DP

Diadema Partners Portfolio holdings

AUM $168M
1-Year Est. Return 163.97%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+163.97%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$144M
AUM Growth
-$17.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
128
New
Increased
Reduced
Closed

Top Buys

1 +$13.9M
2 +$6.07M
3 +$5.32M
4
ASND icon
Ascendis Pharma
ASND
+$5.14M
5
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$4.07M

Top Sells

1 +$14.5M
2 +$11M
3 +$10.2M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$9.76M
5
SLNO icon
Soleno Therapeutics
SLNO
+$7.92M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COGT icon
26
Cogent Biosciences
COGT
$6.04B
$1.4M 0.98%
97,813
-294,400
NVO icon
27
Novo Nordisk
NVO
$163B
$1.39M 0.97%
+25,000
HRMY icon
28
Harmony Biosciences
HRMY
$1.66B
$1.38M 0.96%
+50,000
AMLX icon
29
Amylyx Pharmaceuticals
AMLX
$1.55B
$1.36M 0.95%
+100,000
RNAM
30
DELISTED
Avidity Biosciences
RNAM
$1.31M 0.91%
+30,000
DFTX
31
Definium Therapeutics
DFTX
$1.69B
$1.25M 0.87%
105,891
-52,645
VTGN icon
32
VistaGen Therapeutics
VTGN
$24.2M
$1.24M 0.87%
349,789
-54,133
MNKD icon
33
MannKind Corp
MNKD
$897M
$1.14M 0.79%
+212,475
SUPN icon
34
Supernus Pharmaceuticals
SUPN
$3.13B
$1.07M 0.74%
+22,348
CPRX icon
35
Catalyst Pharmaceutical
CPRX
$2.94B
$985K 0.69%
+50,000
RVPH icon
36
Reviva Pharmaceuticals
RVPH
$25.2M
$924K 0.64%
2,506,921
-228,536
ARCT icon
37
Arcturus Therapeutics
ARCT
$225M
$900K 0.63%
+48,811
TRVI icon
38
Trevi Therapeutics
TRVI
$1.61B
$785K 0.55%
85,830
-100,000
XERS icon
39
Xeris Biopharma Holdings
XERS
$999M
$608K 0.42%
+74,753
CTMX icon
40
CytomX Therapeutics
CTMX
$815M
$591K 0.41%
+185,286
MRNA icon
41
Moderna
MRNA
$19.7B
$517K 0.36%
+20,000
AYTU icon
42
AYTU BioPharma
AYTU
$28.3M
$513K 0.36%
+272,670
TNYA icon
43
Tenaya Therapeutics
TNYA
$119M
$511K 0.36%
+315,519
EQ icon
44
Equillium
EQ
$117M
$429K 0.3%
+300,000
ALEC icon
45
Alector
ALEC
$241M
$403K 0.28%
136,023
-130,000
PRQR icon
46
ProQR Therapeutics
PRQR
$166M
$336K 0.23%
157,694
PYXS icon
47
Pyxis Oncology
PYXS
$91.5M
$333K 0.23%
+150,000
PTHS
48
Pelthos Therapeutics
PTHS
$78.2M
$294K 0.2%
+10,498
RARE icon
49
Ultragenyx Pharmaceutical
RARE
$2.22B
$276K 0.19%
9,189
-44,796
CLYM
50
Climb Bio
CLYM
$482M
$274K 0.19%
136,488
-565,647